- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03300999
The Effects of Daily Ginger Tea Consumption in Reducing Discomfort During Menstruation
Study Overview
Detailed Description
- Day 1: Subjects will sign informed consent and will go over the introduction, purpose, procedures, and compliance with student investigators. Subjects will then be given a sample of ginger tea that will be used for the study and will be asked if they think they can drink this daily for a month. They will also be asked if they have regular menstrual cycles and agree to stop home remedies and stop taking pain medications or herbal supplements for a period of three menstruation cycles.
- Start/During the first menstruation cycle: Subjects will meet with student investigators at a convenient location to the subject and will complete surveys and questionnaires. Subjects will be given visual analog pain scales and symptom checklists that need to be completed during their second menstruation cycle.
- End of the first menstruation cycle - Start of the second menstruation cycle: Subjects will not take ginger tea, avoid home remedies, and refrain from taking pain medications or supplements.
- Start of the second menstruation cycle - End of the second menstruation cycle: Subjects will rate discomfort using the visual analog pain scales and symptom checklist during menstruation. Subjects will meet with student investigators at a convenient location to the subject and will complete surveys and questionnaires. Subjects will be given daily logs, visual analog pain scales, symptom checklists, and supplies for the ginger tea.
- End of the second menstruation cycle - Start of the third menstruation cycle: Subjects will take ginger tea daily, avoid home remedies, refrain from taking pain medications and supplements, and keep track of ginger tea intake by placing a check mark each day in the daily log checklist.
- Start of the third menstruation cycle - End of the third menstruation cycle: Subjects will rate discomfort using the visual analog pains scales and symptom checklist during menstruation.
- After the third menstruation cycle ends: Subjects will meet with student investigators at a location convenient to the subject to turn in daily logs, visual analog pain scales, and symptom checklists.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Loma Linda, California, United States, 92350
- Loma Linda Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- female within age range
- regular menstrual cycles
- experiencing period cramps
- agrees to refrain from taking any pain medications, herbal supplements, or use home remedies such as heating pads that are known to alleviate menstrual cramps during the study period
- after sampling the ginger tea, the subject must agree to drink ginger tea daily.
Exclusion Criteria:
- women who take oral contraceptives
- work night shifts
- allergic to ginger
- lactating
- female-related uterine problems such as fibroids and polycystic ovarian syndrome who suffer from secondary dysmenorrhea
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Ginger Tea
|
1. Ginger tea - Swanson Organic: 100% Certified Organic Ginger Root Tea • Subjects will use one tea bag (contains two grams ginger root), mix with eight ounces of boiling water, steep for three minutes, and allow it to cool to room temperature before drinking. This will be done every day for one month before their third menstruation cycle and during their third menstruation cycle. |
No Intervention: No Ginger Tea
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analog Pain Scale
Time Frame: Change between Day 1 of the Second Menstruation Cycle and Day 28 of the Second Menstruation Cycle. Cycle is 28 days.
|
• The Visual Analogue scale is a form of a Likert scale that gives the interviewee maximum freedom to estimate their pain intensity.
The interviewee will mark a line along the 10-cm scale which they perceive corresponds best to their exact pain intensity every day for the duration of the study.
A score of zero indicated no pain and a score of 10 indicated the most severe pain felt.
|
Change between Day 1 of the Second Menstruation Cycle and Day 28 of the Second Menstruation Cycle. Cycle is 28 days.
|
Visual Analog Pain Scale
Time Frame: Change between Day 1 of the Third Menstruation Cycle and Day 28 of the Third Menstruation Cycle. Cycle is 28 days.
|
• The Visual Analogue scale is a form of a Likert scale that gives the interviewee maximum freedom to estimate their pain intensity.
The interviewee will mark a line along the 10-cm scale which they perceive corresponds best to their exact pain intensity every day for the duration of the study.
A score of zero indicated no pain and a score of 10 indicated the most severe pain felt.
|
Change between Day 1 of the Third Menstruation Cycle and Day 28 of the Third Menstruation Cycle. Cycle is 28 days.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SF-36 Quality of Life Survey
Time Frame: On any day between Day 1 and Day 28 of the first menstruation cycle. Cycle is 28 days.
|
RAND developed this validated survey and it is a set of generic, coherent, and easily administered quality-of-life measures.
These measures rely upon patient self-reporting and are now widely utilized by managed care organizations and by Medicare for routine monitoring and assessment of care outcomes in adult patients.
This survey consists of eight scaled scores which are the weighted sums of the questions in each section.
The sections include vitality, physical functioning, bodily pain, physical role functioning, general health perception, emotional role functioning, social role functioning, and mental health.
Each scale is transformed into a 0-100 scale and the lower score indicates more disability while the higher represents less disability.
It can take participants at least half an hour to complete and will be assessed over a one-month period.
|
On any day between Day 1 and Day 28 of the first menstruation cycle. Cycle is 28 days.
|
SF-36 Quality of Life Survey
Time Frame: Day 28 of the second menstruation cycle. Cycle is 28 days.
|
RAND developed this validated survey and it is a set of generic, coherent, and easily administered quality-of-life measures.
These measures rely upon patient self-reporting and are now widely utilized by managed care organizations and by Medicare for routine monitoring and assessment of care outcomes in adult patients.
This survey consists of eight scaled scores which are the weighted sums of the questions in each section.
The sections include vitality, physical functioning, bodily pain, physical role functioning, general health perception, emotional role functioning, social role functioning, and mental health.
Each scale is transformed into a 0-100 scale and the lower score indicates more disability while the higher represents less disability.
It can take participants at least half an hour to complete and will be assessed over a one-month period.
|
Day 28 of the second menstruation cycle. Cycle is 28 days.
|
SF-36 Quality of Life Survey
Time Frame: Day 28 of the third menstruation cycle. Cycle is 28 days.
|
RAND developed this validated survey and it is a set of generic, coherent, and easily administered quality-of-life measures.
These measures rely upon patient self-reporting and are now widely utilized by managed care organizations and by Medicare for routine monitoring and assessment of care outcomes in adult patients.
This survey consists of eight scaled scores which are the weighted sums of the questions in each section.
The sections include vitality, physical functioning, bodily pain, physical role functioning, general health perception, emotional role functioning, social role functioning, and mental health.
Each scale is transformed into a 0-100 scale and the lower score indicates more disability while the higher represents less disability.
It can take participants at least half an hour to complete and will be assessed over a one-month period.
|
Day 28 of the third menstruation cycle. Cycle is 28 days.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kyndra Woosley, MS RD, Loma Linda University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 5170302
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Discomfort
-
University of FloridaLallemand Health SolutionsActive, not recruitingMenstrual DiscomfortUnited States
-
Seoul National University Bundang HospitalActive, not recruitingDigestive DiscomfortKorea, Republic of
-
Canopy Growth CorporationJames Madison UniversityCompleted
-
Abyss IngredientsArtialisCompletedKnee DiscomfortBelgium
-
Probi ABTerminatedAbdominal DiscomfortGermany
-
Assistance Publique - Hôpitaux de ParisCompleted
-
University of North Carolina, Chapel HillCompletedMedical Device Discomfort | Application Site DiscomfortUnited States
-
University of MemphisCompleted
-
Avicenna NutraceuticalBioScreen Testing ServicesCompletedJoint DiscomfortUnited States
-
Kaohsiung Medical University Chung-Ho Memorial...Unknown
Clinical Trials on ginger tea
-
National Taiwan University HospitalUnknownHealthy Subjects With Different ConstitutionsTaiwan
-
British University In EgyptCompletedHypertension | Diabetes Mellitus | Xerostomia | Post COVID-19 ConditionEgypt
-
Joel YarmushCompletedNausea | VomitingUnited States
-
Emily DiMango, MDNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Georgetown UniversityCompletedDiabetes MellitusUnited States
-
Providence Health & ServicesCompletedMetastatic Sarcoma | Metastatic Carcinoma | Metastatic LymphomaUnited States
-
University of ArizonaUnited States Department of DefenseCompletedLung Cancer Prevention
-
University of Missouri-ColumbiaCompletedGlucose | Blood Sugar; High | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
Aberystwyth UniversityTeTrimTeas CyfActive, not recruitingObesity | Well-beingUnited Kingdom
-
Transtimulation Research, IncNational Center for Complementary and Integrative Health (NCCIH); Texas Tech... and other collaboratorsCompleted